Seamus Mulligan

Companies

• Jazz PharmaceuticalsBoard member Jan 18, 2012 to now¹
• Emergent BioSolutionsBoard member Mar 21, 2019 to Mar 21, 2019²
• Jazz PharmaceuticalsOfficer Jan 18, 2012 to Jan 18, 2012¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• JPJazz Pharmaceuticals JAZZ1,286,254 shares³$266.3M at $207.05Aug 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 5, 2026Granted 1,605 shares of Jazz Pharmaceuticals³
• May 28, 2026Exercised options 3,415 shares at $138.08 of Jazz Pharmaceuticals⁴
• Aug 7, 2025Granted 3,507 shares of Jazz Pharmaceuticals⁵
• May 12, 2025Bought 1,621 shares at $103.00 of Jazz Pharmaceuticals⁶
• May 9, 2025Bought 100 shares at $99.71 of Jazz Pharmaceuticals⁶
• May 9, 2025Bought 19,216 shares at $98.91 of Jazz Pharmaceuticals⁶
• May 9, 2025Bought 80,684 shares at $98.10 of Jazz Pharmaceuticals⁶
• Aug 2, 2024Granted 3,731 shares of Jazz Pharmaceuticals⁷
• Aug 11, 2023Granted 3,075 shares of Jazz Pharmaceuticals⁸
• Jun 8, 2023Exercised options 4,500 shares at $81.76 of Jazz Pharmaceuticals⁹
• Mar 4, 2023Exercised options 4,500 shares at $59.13 of Jazz Pharmaceuticals¹⁰
• Aug 5, 2022Granted 2,561 shares of Jazz Pharmaceuticals¹¹